Development of patient-derived xenograft (PDX) models for small cell lung cancer (SCLC) as a preclinical platform for drug development

被引:0
|
作者
Mullins, Chelsea [1 ]
Ricono, Jill [1 ]
Nair, Praveen [1 ]
Mirsaidi, Cyrus [1 ]
Broudy, Thomas [1 ]
机构
[1] Mol Response, San Diego, CA USA
关键词
D O I
10.1158/1538-7445.AM2015-4209
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4209
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Development of a Pathway-Directed Drug Screen Platform for Cutaneous T Cell Lymphoma Using Patient-Derived Xenograft Models
    Wu, Chi-Heng
    Yang, Chen-Yen
    Wang, Linlin
    Gao, Hua-Xin
    Taha, Rakhshandehroo
    Afghani, Shervin
    Pincus, Laura
    Balassanian, Ronald
    Rubenstein, James
    Gill, Ryan
    Bandyopadhyay, Sourav
    McCormick, Frank
    Moasser, Mark
    Ai, Weiyun Z.
    BLOOD, 2019, 134
  • [42] Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration
    Fuchs, Vered
    Sobarzo, Ariel
    Msamra, Maha
    Kezerle, Yarden
    Linde, Liat
    Sevillya, Gur
    Anoze, Alaa
    Refaely, Yael
    Cohen, Ahron Yehonatan
    Melamed, Israel
    Azriel, Amit
    Shoukrun, Rami
    Raviv, Yael
    Porgador, Angel
    Peled, Nir
    Roisman, Laila Catalina
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (09): : 2227 - 2239
  • [43] Development and validation of a patient derived xenograft based preclinical platform for immuno-oncology drug development
    Oswald, E.
    Grote, A.
    Bug, D.
    Loehr, A.
    Lenhardt, D.
    Niedermann, G.
    Merhof, D.
    Feuerhake, F.
    Schueler, J.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S108 - S108
  • [44] Development of a panel of breast cancer patient-derived xenograft models (PDX) with estrogen independence and/or acquired resistance to endocrine treatment
    de Boisferon, Marc Hillairet
    Benzaid, Ismahene
    Chatel, Elodie Marie Dit
    Hoffmann, Nicolas
    Littlefield, Bruce
    CANCER RESEARCH, 2020, 80 (16)
  • [45] Patient-derived xenograft (PDX) paraclinical platform to guide precision medicine in urothelial cancer
    Pan, Chong-Xian
    Zhang, Hongyong
    Tepper, Clifford
    Ghosh, Paramita
    Kuslak-Meyer, Sheri
    Airhart, Susie
    Gill, Parkash
    Gandara, David
    Liu, Edison
    White, Ralph de Vere
    CANCER RESEARCH, 2014, 74 (19)
  • [46] UTILIZATION OF PATIENT-DERIVED TUMOR XENOGRAFT (PDX) MODELS IN ONCOLOGY
    Cybula, Magdalena
    Moxley, Katherine
    Wang, Lin
    Wang, Luyao
    Bieniasz, Magdalena
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 84 - 84
  • [47] Patient-derived cell line, xenograft and organoid models in lung cancer therapy
    Huo, Ku-Geng
    D'Arcangelo, Elisa
    Tsao, Ming-Sound
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (05) : 2214 - 2232
  • [48] Evaluation of patient-derived cell lines and cancer organoids for the prediction of drug responses in patient-derived xenograft models
    Campbell, Petreena
    Hose, Curtis
    El Touny, Lara
    Harris, Erik
    Connelly, John
    Bonomi, Carrie
    Dougherty, Kelly
    Styers, Savanna
    Walke, Abigail
    Moyer, Jenna
    Baldwin, Mariah
    Wade, Anna
    Mullendore, Michael
    Arthur, Kaitlyn
    Murphy, Matthew
    Plater, Kevin
    Gibson, Marion
    Geraghty, Joseph
    Gottholm-Ahalt, Michelle
    Grinnage-Pulley, Tara
    Chase, Tiffanie
    Carter, John
    Stotler, Howard
    Trail, Debbie
    Stockwin, Luke
    Newton, Dianne
    Evrard, Yvonne
    Hollingshead, Melinda
    Parchment, Ralph E.
    Coussens, Nathan P.
    Teicher, Beverly A.
    Doroshow, James H.
    Rapisarda, Annamaria
    CANCER RESEARCH, 2020, 80 (16)
  • [49] Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
    Heo, Eun Jin
    Cho, Young Jae
    Cho, William Chi
    Hong, Ji Eun
    Jeon, Hye-Kyung
    Oh, Doo-Yi
    Choi, Yoon-La
    Song, Sang Yong
    Choi, Jung-Joo
    Bae, Duk-Soo
    Lee, Yoo-Young
    Choi, Chel Hun
    Kim, Tae-Joong
    Park, Woong-Yang
    Kim, Byoung-Gie
    Lee, Jeong-Won
    CANCER RESEARCH AND TREATMENT, 2017, 49 (04): : 915 - 926
  • [50] Development and characterization of a panel of orthotopic glioblastoma multiforme (GBM) patient-derived xenograft (PDX) mouse models for drug efficacy evaluation
    Nielsen, Carsten H.
    Alfsen, Maria Z.
    Wick, Michael J.
    Rundle, Melissa
    Gudbergsson, Johann M.
    Jensen, Mette M.
    Kristensen, Lotte K.
    Juul, Mark U.
    Papadopoulos, Kyriakos P.
    Kjaer, Andreas
    CANCER RESEARCH, 2019, 79 (13)